Corcept Therapeutics Incorporated (CORT)
NASDAQ·Healthcare·Biotechnology
$46.73
+1.10%
Mkt Cap $4.90B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 24, 2026 | $254.94M | $202.13M | -20.72% | $0.33 | $0.20 | -39.39% | — | — |
| Q4 2025 Nov 4, 2025 | $255.35M | $207.64M | -18.68% | $0.18 | $0.16 | -11.11% | — | — |
| Q3 2025 Jul 31, 2025 | $244.58M | $194.43M | -20.50% | $0.23 | $0.29 | +26.09% | — | — |
| Q2 2025 May 5, 2025 | $216.68M | $157.21M | -27.44% | $0.17 | $0.17 | +0.00% | — | — |
| Q1 2025 Feb 26, 2025 | $200.12M | $181.89M | -9.11% | $0.37 | $0.26 | -29.73% | — | — |
| Q4 2024 Oct 30, 2024 | $198.02M | $182.55M | -7.81% | $0.28 | $0.41 | +46.43% | — | — |
| Q3 2024 Jul 29, 2024 | $162.08M | $163.80M | +1.06% | $0.23 | $0.32 | +39.13% | — | — |
| Q2 2024 May 1, 2024 | $141.20M | $146.81M | +3.97% | $0.22 | $0.25 | +13.64% | — | — |
| Q1 2024 Feb 15, 2024 | $129.30M | $135.41M | +4.72% | $0.26 | $0.28 | +7.69% | — | — |
| Q4 2023 Nov 1, 2023 | $127.82M | $123.60M | -3.30% | $0.22 | $0.28 | +27.27% | — | — |
| Q3 2023 Aug 2, 2023 | $109.69M | $117.72M | +7.32% | $0.15 | $0.25 | +66.67% | — | — |
| Q2 2023 May 3, 2023 | $104.87M | $105.65M | +0.75% | $0.19 | $0.14 | -26.32% | — | — |
| Q1 2023 Feb 28, 2023 | $105.08M | $103.06M | -1.93% | $0.23 | $0.14 | -39.13% | — | — |
| Q4 2022 Nov 3, 2022 | $107.57M | $101.73M | -5.43% | $0.23 | $0.30 | +30.43% | — | — |
| Q3 2022 Aug 3, 2022 | $101.00M | $103.39M | +2.36% | $0.24 | $0.24 | +0.00% | — | — |
| Q2 2022 May 5, 2022 | $98.88M | $93.69M | -5.25% | $0.24 | $0.20 | -16.67% | — | — |
| Q1 2022 Feb 15, 2022 | $100.57M | $98.82M | -1.74% | $0.22 | $0.26 | +18.18% | — | — |
| Q4 2021 Nov 3, 2021 | $97.65M | $96.13M | -1.56% | $0.20 | $0.24 | +20.00% | — | — |
| Q3 2021 Jul 29, 2021 | $91.59M | $91.59M | +0.00% | $0.16 | $0.21 | +31.25% | — | — |
| Q2 2021 May 6, 2021 | $88.96M | $79.44M | -10.70% | $0.21 | $0.18 | -14.29% | — | — |